ResQ Pharma: Funding, Investors & Team (Sep 2026)
ResQ Pharma is an examination and improvement organization. Its lead program, LipidRescue Therapy (LRT) is a generally involved off-name treatment for different non-sedative medication excesses and poisonings including every nearby sedative (Lidocaine, Bupivacaine, etc...), benzodiazepines and psychotherapeutics (all antidepres). The Company was shaped to popularize LRT which is a reusing of a lipid emulsion that is FDA and EMA endorsed as a dietary enhancement. ResQ Pharma intends to record applications for market endorsement for both the EU and USA by the first quarter of 2017. Applications for Orphan Drug Designation are forthcoming with both the FDA and EMA right now. This lipid emulsion has been utilized all over the planet starting around 2010 as Lipid Rescue Therapy (LRT). The issue is that it isn't regulatorily supported as a treatment for excesses and poisonings. Consequently it can't be showcased and numerous in the medical care local area don't know about item. Around 47,000 individuals kicked the bucket in 2015 from drug excesses and poisonings, roughly 40% likely treatable with LRT.
ResQ Pharma has raised $210k across 1 funding round on record, the most recent an undisclosed round of $210k announced in Jun 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ResQ Pharma Company Profile and Key Stats
Latest funding round on record: Jun 2022.
ResQ Pharma Funding Rounds
ResQ Pharma Founders and Leadership Team
No contact details are on record for this team yet.
ResQ Pharma Funding Compared to Other Biotechnology Startups
ResQ Pharma's latest round of $210k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ResQ Pharma in Biotechnology and Chicago
Companies Similar to ResQ Pharma
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
ResQ Pharma Funding FAQs
What does ResQ Pharma do?
ResQ Pharma is an examination and improvement organization. Its lead program, LipidRescue Therapy (LRT) is a generally involved off-name treatment for different non-sedative medication excesses and poisonings including every nearby sedative (Lidocaine, Bupivacaine, etc...), benzodiazepines and psychotherapeutics (all antidepres). The Company was shaped to popularize LRT which is a reusing of a lipid emulsion that is FDA and EMA endorsed as a dietary enhancement. ResQ Pharma intends to record applications for market endorsement for both the EU and USA by the first quarter of 2017. Applications for Orphan Drug Designation are forthcoming with both the FDA and EMA right now. This lipid emulsion has been utilized all over the planet starting around 2010 as Lipid Rescue Therapy (LRT). The issue is that it isn't regulatorily supported as a treatment for excesses and poisonings. Consequently it can't be showcased and numerous in the medical care local area don't know about item. Around 47,000 individuals kicked the bucket in 2015 from drug excesses and poisonings, roughly 40% likely treatable with LRT.
How much funding has ResQ Pharma raised?
ResQ Pharma has raised $210k across 1 round on record. The most recent is an undisclosed round of $210k announced in Jun 2022.
When did ResQ Pharma last raise funding?
ResQ Pharma's most recent funding round on record is an undisclosed round of $210k, announced in Jun 2022.
Who founded ResQ Pharma?
FundedIQ lists Paul Hertz (Founder) at ResQ Pharma.
Where is ResQ Pharma headquartered?
ResQ Pharma is based in Chicago, Illinois, United States.
How many employees does ResQ Pharma have?
ResQ Pharma is in the 11-50 employee band.
How does ResQ Pharma's funding compare to other Biotechnology startups?
ResQ Pharma's latest round of $210k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's ResQ Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ResQ Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.